We are a joung bio-technology start-up working the unqiue bio-technology platform Adena Intel that leverages recent advancements in artifical intelligence to create novel biopharmaceutical drugs. Based in Zurich (CH), our mission is to
- Identify novel drug candidates based on AI recommendation.
- Rapid drug candidate evaluation through protein simulaton.
- Leverage existing pharmaceuticals for novel conditions.
Data Sets of on the market drugs analyzed by our Adena Intel platform.
Projects to evaluate novel drug candidates suggested by our Adena Intel platform
Years of experience in the bio-technology area across our team
Leverage the power of artifical intelligence for drug candidate research.
Relyable simulation of protein models to systematicaly determine their effects.
Significantly accelerate drug discovery and research through our protein models.
Identify novel drug candidates based on AI-driven protein simulation.
Magnam dolores commodi suscipit eum quidem consectetur velit
This team combines a unique experience with outstanding ideas. Their approach could be a game changer for the bio-technology industry!
The combination of technological and bio-sience knwoledge in your team massivly impressed me. Can't wait to see the first results!
Andreas HansenChief Executive Officer
Sarah JhonsonResearch Lead
Pioneering Novel Biopharmaceuticals
Zurich, ZH 8041, CH
+41 78 222 42 74